iAngels
Israel
- Tel Aviv
- 02/12/2022
- Series B
- $42,000,000
Founded in 2014 by Shelly Hod Moyal, Mor Assia and David Assia, iAngels is a venture capital firm and investment platform. iAngels offers accredited investors worldwide exclusive access to tech startups and scaleup investment opportunities originated in Israel and curated through a streamlined due-diligence process. Through iAngels’ various investment offerings, investors can choose to invest in specific startups, create a personalized VC portfolio of tech companies or join our iAngels Ventures Fund, an institutional fund backed by the European Investment Fund, partnering with some of the highest caliber entrepreneurs in the nation.
With over $400m AUM, and a global network of 5,000 accredited investors, iAngels is one of the most active investors in the Israeli tech ecosystem. iAngels works closely with family offices, institutions, and private investors globally and offers tailored offerings for each field of expertise.
Find out more at: www.iAngels.com
- Industry Venture Capital and Private Equity Principals
- Website https://www.iangels.com/
- LinkedIn https://www.linkedin.com/company/iangels/
Related People
Shelly Hod MoyalInvestor
Israel -
Tel Aviv-Yafo, Tel Aviv District
Shelly Hod Moyal is Founding Partner and Co-CEO of iAngels, and General Partner of iAngels Ventures I
An international finance and investment expert, Shelly leads iAngels with a compelling and hands-on approach to the firm's investment due diligence process, investor relations and portfolio management of the iAngels platform, and institutional fund, iNgenuity.
Shelly’s experience as an investment banker with Goldman Sachs, and research analyst at Avenue Capital, equip her to reality-test the growth plans of early-stage innovative companies, make data-driven investment decisions, and architect deal terms to ensure equitable profitability between investors and entrepreneurs. She is an active investor who accelerates companies' enterprise growth with marketing, finance, recruiting, fundraising and business development efforts.
A Kellogg MBA graduate, Shelly is a sought-after authority for international conferences regarding Israeli tech investing across disparate verticals. She serves as a board member of numerous portfolio companies under iAngels' purview.
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)